Skip to main content

Evogene Ltd.

EVGN
Exchange
Nasdaq
Industry
Agricultural Chemicals
SEC CIK
0001574565

In the last 90 days, Evogene Ltd. insiders filed 3 open-market purchases and 0 sales; 13 institutions reported holding it in 13F filings for Q2 2026, worth $120.0K in total; no superinvestor holds it.

13F holders, Q1 2026

Institutional positions in Evogene Ltd. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
15
−3 vs. Q4 2025
Shares held
530.6K
+348.9K (+192.0%) vs. Q4 2025
Total value
$408.9K
+$209.0K (+104.6%) vs. Q4 2025
New holders
2
1 more added
Sold out
5
5 more reduced

Compare with Q4 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting EVGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2026: 15 institutions
Q1 2021: 46 institutionsQ2 2021: 44 institutionsQ3 2021: 39 institutionsQ4 2021: 43 institutionsQ1 2022: 38 institutionsQ2 2022: 29 institutionsQ3 2022: 26 institutionsQ4 2022: 31 institutionsQ1 2023: 27 institutionsQ2 2023: 28 institutionsQ3 2023: 35 institutionsQ4 2023: 33 institutionsQ1 2024: 29 institutionsQ2 2024: 28 institutionsQ3 2024: 14 institutionsQ4 2024: 15 institutionsQ1 2025: 16 institutionsQ2 2025: 16 institutionsQ3 2025: 14 institutionsQ4 2025: 18 institutionsQ1 2026: 15 institutionsQ2 2026: 13 institutions
Value heldQ1 2026: $408.9K
Q1 2021: $42.1MQ2 2021: $25.3MQ3 2021: $16.7MQ4 2021: $10.0MQ1 2022: $3.18MQ2 2022: $1.25MQ3 2022: $1.21MQ4 2022: $753.9KQ1 2023: $500.6KQ2 2023: $759.5KQ3 2023: $2.73MQ4 2023: $3.69MQ1 2024: $3.04MQ2 2024: $2.55MQ3 2024: $1.70MQ4 2024: $751.6KQ1 2025: $526.9KQ2 2025: $166.9KQ3 2025: $176.1KQ4 2025: $199.8KQ1 2026: $408.9KQ2 2026: $120.0K
Institutions holding EVGN and their total value by quarter
QuarterHoldersValue
Q2 202613$120.0K
Q1 202615$408.9K
Q4 202518$199.8K
Q3 202514$176.1K
Q2 202516$166.9K
Q1 202516$526.9K
Q4 202415$751.6K
Q3 202414$1.70M
Q2 202428$2.55M
Q1 202429$3.04M
Q4 202333$3.69M
Q3 202335$2.73M
Q2 202328$759.5K
Q1 202327$500.6K
Q4 202231$753.9K
Q3 202226$1.21M
Q2 202229$1.25M
Q1 202238$3.18M
Q4 202143$10.0M
Q3 202139$16.7M
Q2 202144$25.3M
Q1 202146$42.1M

Institutions, Q1 2026

Shares, value and share of portfolio for each institution holding Evogene Ltd.; share changes are against Q4 2025.

Institutions holding EVGN in Q1 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Armistice Capital, LLC456,587$351.6K0.01%+456,587New
Jane Street Group, LLC18,500$14.2K0.00%−19,442−51.2%Reduced
XTX Topco Ltd12,721$9.79K0.00%−9,963−43.9%Reduced
Two Sigma Securities, LLC12,465$9.60K0.00%+12,465New
Daytona Street Capital LLC9,586$7.70K0.01%00.0%Unchanged
BNP Paribas Arbitrage, SA9,124$7.03K0.00%−1,000−9.9%Reduced
UBS Group AG6,352$4.89K0.00%+5,155+430.7%Added
Morgan Stanley3,851$2.96K0.00%−5,200−57.5%Reduced
Steward Partners Investment Advisory, LLC505$3890.00%00.0%Unchanged
Federation des caisses Desjardins du Quebec500$3850.00%00.0%Unchanged
Tradewinds Capital Management, LLC131$1010.00%00.0%Unchanged
Advisor Group Holdings, Inc.100$770.00%−50−33.3%Reduced
SBI Securities Co., Ltd.72$550.00%00.0%Unchanged
SHP Wealth Management65$500.00%00.0%Unchanged
Royal Bank of Canada42$00.00%00.0%Unchanged
Citadel Advisors LLC0$00.00%−88,764−100.0%Sold out
Altshuler Shaham Ltd0$00.00%−750−100.0%Sold out
Bank of America Corp0$00.00%−159−100.0%Sold out
Russell Investments Group, Ltd.0$00.00%−1−100.0%Sold out
Farther Finance Advisors, LLC0$00.00%−1−100.0%Sold out